16.58
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
Medical Maggots Market Hits New High | Major Giants BioMonde, Maggot Therapy, MediWound - openPR.com
Performance Recap: Is MediWound Ltd forming a bullish divergenceDip Buying & AI Optimized Trading Strategy Guides - baoquankhu1.vn
FY2030 Earnings Estimate for MediWound Issued By Maxim Group - Defense World
Institution Moves: Does MediWound Ltd meet Warren Buffetts criteria2026 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
FY2030 Earnings Forecast for MediWound Issued By Maxim Group - MarketBeat
MediWound Is the Biotech Governments Have Been Stockpiling for E - GuruFocus
MediWound Is the Biotech Governments Have Been Stockpiling for Exactly These Kinds of Wars (NASDAQ: MDWD) - TradingView
MediWound (MDWD) Q4 2025 Earnings Call Transcript - AOL.com
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Behavioral Patterns of MDWD and Institutional Flows - Stock Traders Daily
MediWound (NASDAQ:MDWD) Stock Rating Lowered by Wall Street Zen - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Q4 2025 Earnings Call Transcript - Insider Monkey
MediWound: Q4 Earnings Snapshot - theheraldreview.com
MediWound Posts 2025 Loss but Strengthens Cash and Advances EscharEx, NexoBrid Capacity - The Globe and Mail
Mediwound earnings beat by $0.03, revenue fell short of estimates - Investing.com Australia
MediWound Q4 Earnings Call Highlights - MarketBeat
MediWound (MDWD) Heavy FY 2025 Losses Test High Growth And Premium P/S Narrative - simplywall.st
MediWound Q4 2025 Earnings Call Transcript - MarketBeat
MediWound Files Annual Report on Form 20-F - Bluefield Daily Telegraph
MediWound Ltd. Q4 2025 Earnings Call Summary - Yahoo Finance
MediWound (NASDAQ:MDWD) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
MDWD: Expanded manufacturing, clinical progress, and strong guidance despite 2025 revenue decline - TradingView
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
MDWD Maintains Revenue Forecasts Through 2028 - GuruFocus
MediWound (MDWD) Reports Lower-than-Expected Q4 Revenue - GuruFocus
MediWound: Overview of Fourth Quarter Financial Results - Bitget
MEDIWOUND ($MDWD) Releases Q4 2025 Earnings - Quiver Quantitative
MediWound (NASDAQ: MDWD) posts 2025 loss with cash rising above $53M - Stock Titan
Insights into MediWound Q4 Earnings - Benzinga
MediWound Ltd. recently announced that it has once again confirmed its financial forecast targets for the coming years. - Bitget
What to Expect from MediWound's Earnings - Benzinga
Earnings Preview: MediWound to Report Financial Results Pre-market on March 05 - 富途牛牛
Mediwound Ltd expected to post a loss of 63 cents a shareEarnings Preview - TradingView
MediWound at TD Cowen Conference: Strategic Growth and Market Expansion - Investing.com Nigeria
MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference - MarketBeat
Clal Insurance Enterprises Holdings Ltd Acquires New Position in MediWound Ltd. $MDWD - MarketBeat
MediWound at Oppenheimer Conference: Strategic Growth and Innovation - Investing.com Australia
MediWound (MDWD) Expected to Announce Earnings on Thursday - MarketBeat
(MDWD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MediWound (NASDAQ:MDWD) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Will MediWound Ltd. stock benefit from green energy trendsEarnings Summary Report & Safe Swing Trade Setups - mfd.ru
MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool - The Globe and Mail
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results - Bitget
Will MediWound Ltd. stock outperform international peersJuly 2025 Spike Watch & Fast Entry and Exit Trade Plans - mfd.ru
MediWound Ltd. (NASDAQ:MDWD) Short Interest Up 20.9% in January - MarketBeat
MediWound to Present at Upcoming Investor Conferences - Bitget
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):